Detalles de la búsqueda
1.
Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.
Breast Cancer Res
; 25(1): 133, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919764
2.
Inhibition of MHC-I by Brucella abortus is an early event during infection and involves EGFR pathway.
Immunol Cell Biol
; 95(4): 388-398, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27811842
3.
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
BMC Cancer
; 17(1): 895, 2017 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29281999
4.
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Breast Cancer Res
; 16(6): 491, 2014 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25479686
5.
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
J Immunol
; 189(3): 1162-72, 2012 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22753933
6.
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.
Breast Cancer Res
; 15(6): R118, 2013 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-24345432
7.
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression.
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889811
8.
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Breast Cancer Res
; 14(3): R77, 2012 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22583478
9.
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer.
BMC Cancer
; 12: 74, 2012 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22356700
10.
Influence of conformationally restricted pyrimidines on the activity of 10-23 DNAzymes.
Bioorg Med Chem
; 20(8): 2581-6, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22429508
11.
Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer.
Cell Death Dis
; 13(5): 447, 2022 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35534460
12.
Regulation of telomere homeostasis and genomic stability in cancer by N 6-adenosine methylation (m6A).
Sci Adv
; 7(31)2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34321211
13.
Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
Breast Cancer Res Treat
; 122(1): 111-24, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19760502
14.
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer.
Front Oncol
; 10: 584, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32391269
15.
Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy.
Oncoimmunology
; 9(1): 1715767, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32064174
16.
Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.
Oncogene
; 39(39): 6245-6262, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32843720
17.
Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis.
Horm Cancer
; 11(5-6): 218-239, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32632815
18.
Nuclear ErbB-2: a Novel Therapeutic Target in ErbB-2-Positive Breast Cancer?
Horm Cancer
; 10(2-3): 64-70, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30656558
19.
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Mol Cell Biol
; 25(12): 4826-40, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15923602
20.
Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Mol Endocrinol
; 21(6): 1335-58, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17440047